214 related articles for article (PubMed ID: 35744039)
1. Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study.
Akad M; Socolov R; Furnică C; Covali R; Stan CD; Crauciuc E; Pavaleanu I
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744039
[No Abstract] [Full Text] [Related]
2. Treatments in Patients with Polycystic Ovary Syndrome and Effects on Kisspeptin Serum Levels.
Akad M; Socolov D; Akad F; Covali R; Crauciuc E; Stan C; Stan C; Socolov R
Maedica (Bucur); 2022 Dec; 17(4):799-804. PubMed ID: 36818240
[No Abstract] [Full Text] [Related]
3. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
4. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
5. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome.
Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T
Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245
[No Abstract] [Full Text] [Related]
6. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women.
Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS
J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.
Pratama G; Wiweko B; Asmarinah ; Widyahening IS; Andraini T; Bayuaji H; Hestiantoro A
Sci Rep; 2024 Apr; 14(1):8229. PubMed ID: 38589425
[TBL] [Abstract][Full Text] [Related]
8. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
[TBL] [Abstract][Full Text] [Related]
9. The role of kisspeptin in the pathogenesis of a polycystic ovary syndrome.
Aasif A; Alam R; Ahsan H; Khan MM; Khan A; Khan S
Endocr Regul; 2023 Jan; 57(1):292-303. PubMed ID: 38127687
[TBL] [Abstract][Full Text] [Related]
10. Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China.
Zhao T; Zhang Q; Xiao X; Tao X; Gao M; He W; Wu X; Yuan T
Gynecol Endocrinol; 2022 Sep; 38(9):790-794. PubMed ID: 35903815
[TBL] [Abstract][Full Text] [Related]
11. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
[TBL] [Abstract][Full Text] [Related]
12. Kisspeptin and LH pulsatile temporal coupling in PCOS patients.
Katulski K; Podfigurna A; Czyzyk A; Meczekalski B; Genazzani AD
Endocrine; 2018 Jul; 61(1):149-157. PubMed ID: 29728876
[TBL] [Abstract][Full Text] [Related]
13. Kisspeptin levels in relation to sex hormone profile among PCOS patients.
Zarei E; Binabaj MM; Zadeh FM; Bakhshandeh Nosrat S; Veghari G; Mansourian A
Ir J Med Sci; 2022 Aug; 191(4):1711-1716. PubMed ID: 34378162
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome (PCOS) and kisspeptin - A Sri Lankan study.
Umayal B; Jayakody SN; Chandrasekharan NV; Wijesundera WS; Wijeyaratne CN
J Postgrad Med; 2019; 65(1):18-23. PubMed ID: 30004037
[TBL] [Abstract][Full Text] [Related]
15. Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome.
Mut A; Erel CT; İnan D; Öner YÖ
Gynecol Endocrinol; 2021 May; 37(5):462-466. PubMed ID: 32964765
[TBL] [Abstract][Full Text] [Related]
16. Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Hum Reprod; 2020 Jun; 35(6):1421-1431. PubMed ID: 32510130
[TBL] [Abstract][Full Text] [Related]
17. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
18. Role of kisspeptin in polycystic ovary syndrome (PCOS).
Emekci Ozay O; Ozay AC; Acar B; Cagliyan E; Seçil M; Küme T
Gynecol Endocrinol; 2016 Sep; 32(9):718-722. PubMed ID: 27003383
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome?
Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N
Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of serum Kisspeptin levels among women with Polycystic Ovary Syndrome and normal fertile women.
Hassan Ali MA; Mohamad SR
J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S97-S100. PubMed ID: 35130228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
